Sarcopenia is the core factor of frailty. This study specifically focused on lower limb muscle strength and examined muscle indices that indicate the risk of frailty or pre-frailty in older adults. The study included 327 community-dwelling individuals aged ≥65 years (43.7% male) who participated in the cohort. Frailty was defined based on five symptoms: weight loss, low activity level, exhaustion, weakness and slowness. Participants were classified into frail (three or more applicable), pre-frail (one to two applicable) and non-frail groups. Muscle strength (knee extension strength, toe grip strength and hand grip strength) were assessed, and appendicular muscle mass was assessed via a bioelectrical impedance analysis. The adjusted odds ratio (OR) of muscle indices for with frailty (frail group vs. pre-frail group) or pre-frailty (pre-frail group vs. non-frail group) were calculated. The prevalence of frail and pre-frail was 7% and 40%, respectively. Adjusted for age, sex, albumin and medical history, knee extension strength was significantly associated with frailty (odds ratio 0.95, 95% CI 0.92-0.98), while hand grip strength was associated with pre-frailty (odds ratio 0.92, 95% CI 0.88-0.97) but not with other muscle indices. This study is significant for identifying knee extension strength as a factor relevant to frailty in older adults considered pre-frailty, emphasizing the importance of this specific muscle measure in predicting and managing frailty.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10801561 | PMC |
http://dx.doi.org/10.3390/geriatrics9010009 | DOI Listing |
Rheumatol Ther
January 2025
Biosplice Therapeutics, Inc., 9360 Towne Centre Dr, San Diego, CA, 92121, USA.
Introduction: Lorecivivint (LOR), a CDC-like kinase/dual-specificity tyrosine kinase (CLK/DYRK) inhibitor thought to modulate inflammatory and Wnt pathways, is being developed as a potential intra-articular knee osteoarthritis (OA) treatment. The objective of this trial was to evaluate long-term safety of LOR within an observational extension of two phase 2 trials.
Methods: This 60-month, observational extension study (NCT02951026) of a 12-month phase 2a trial (NCT02536833) and 6-month phase 2b trial (NCT03122860) was administratively closed after 36 months as data inferences became limited.
J Appl Biomech
January 2025
Rehabilitation Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Knee osteoarthritis (KOA) can have more pronounced effects on joint position sense (JPS) accuracy and gait characteristics. The aim of this study is to investigate the association between lower limb JPS and different aspects of gait pattern including gait asymmetry and variability and spatiotemporal coordination in individuals with bilateral KOA. In this cross-sectional study, lower limb JPS of 43 individuals with bilateral KOA (mild and moderate) were measured.
View Article and Find Full Text PDFJ Appl Biomech
January 2025
Lancaster Medical School, Faculty of Health and Medicine, Lancaster University, Lancaster, United Kingdom.
This study compares joint kinematics and kinetics of young stroke survivors who walk <0.79 m/s (slow) or >0.80 m/s (fast) with reference to a healthy able-bodied group and provides clinical recommendations for guiding the gait rehabilitation of stroke survivors.
View Article and Find Full Text PDFInt J Surg Case Rep
December 2024
Department of Sports Medicine, Yueyang Hospital Affiliated to Hunan Normal University, Yueyang, Hunan Province, China. Electronic address:
Introduction And Importance: Calcific tendinitis occurring in the popliteal tendon is extremely rare and has rarely been reported in the past. This case describes a patient who underwent arthroscopic surgery to remove the calcification of the popliteal tendon and achieved satisfactory results after surgery, providing valuable evidence for the feasibility of arthroscopic treatment of calcific tendinitis of the popliteal tendon.
Case Presentation: The patient was a 55-year-old female who was admitted to the hospital due to right knee pain and limited mobility.
Objective: This study investigated the effects of a single dose injection of mesenchymal stem cells (MSCs) under ultrasound guidance for knee osteoarthritis (KOA).
Design: The study included 30 subjects in the intervention group, who received the MSC injection and 27 in the control group who received triamcinolone. Various outcome measures, including pain levels, range of motion (ROM), and MRI parameters, were evaluated before the intervention and at different time points after treatment.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!